Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario

por Naipaul, Rohini D., Mercer, Rebecca E., Chan, Kelvin K. W., Yeung, Lyndee, Forbes, Leta, Gavura, Scott
Publicado 2021

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

por Chan, Kelvin, Nam, Seungree, Evans, Bill, de Oliveira, Claire, Chambers, Alexandra, Gavura, Scott, Hoch, Jeffrey, Mercer, Rebecca E, Dai, Wei Fang, Beca, Jaclyn, Tadrous, Mina, Isaranuwatchai, Wanrudee
Publicado 2020

Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?

por Dai, Wei Fang, Beca, Jaclyn, Guo, Helen, Isaranawatchai, Wanrudee, Schwartz, Deborah, Naipaul, Rohini, Arias, Jessica, Qiao, Yao, Gavura, Scott, Redmond‐Misner, Ruby, Ismail, Zahra, Barbera, Lisa, Chan, Kelvin
Publicado 2019

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

por Dai, Wei Fang, Beca, Jaclyn M., Croxford, Ruth, Isaranawatchai, Wanrudee, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Hanna, Timothy P., Chan, Kelvin K.W.
Publicado 2020

Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies i...

por Pataky, Reka E., Beca, Jaclyn, Tran, David, Dai, Wei Fang, Dvorani, Erind, Isaranuwatchai, Wanrudee, Peacock, Stuart, Alvi, Riaz, Cheung, Winson Y., Earle, Craig C., Gavura, Scott, Chan, Kelvin K. W.
Publicado 2021

The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer

por Raphael, Michael J., Raskin, William, Habbous, Steven, Tai, Xiaochen, Beca, Jaclyn, Dai, Wei F., Arias, Jessica, Forbes, Leta, Gavura, Scott, Biagi, James J., Earle, Craig C., Chan, Kelvin K. W.
Publicado 2021

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization

por Lu, Brandon, Dai, Wei Fang, Croxford, Ruth, Isaranuwatchai, Wanrudee, Beca, Jaclyn, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Mercer, Rebecca E., Hanna, Timothy P., Chan, Kelvin K. W.
Publicado 2023

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis

por Khor, Sara, Beca, Jaclyn, Krahn, Murray, Hodgson, David, Lee, Linda, Crump, Michael, Bremner, Karen E, Luo, Jin, Mamdani, Muhammad, Bell, Chaim M, Sawka, Carol, Gavura, Scott, Sullivan, Terrence, Trudeau, Maureen, Peacock, Stuart, Hoch, Jeffrey S
Publicado 2014

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer

por Arciero, Vanessa, Luo, Jin, Parmar, Ambica, Dai, Wei Fang, Beca, Jaclyn M, Raphael, Michael J, Isaranuwatchai, Wanrudee, Habbous, Steven, Tadrous, Mina, Earle, Craig C, Biagi, Jim J, Mittmann, Nicole, Arias, Jessica, Gavura, Scott, Chan, Kelvin K W
Publicado 2022

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

por Chan, Kelvin K. W., Guo, Helen, Cheng, Sierra, Beca, Jaclyn M., Redmond‐Misner, Ruby, Isaranuwatchai, Wanrudee, Qiao, Lucy, Earle, Craig, Berry, Scott R., Biagi, James J., Welch, Stephen, Meyers, Brandon M., Mittmann, Nicole, Coburn, Natalie, Arias, Jessica, Schwartz, Deborah, Dai, Wei F., Gavura, Scott, McLeod, Robin, Kennedy, Erin D.
Publicado 2019

Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada

por Habbous, Steven, Tai, Xiaochen, Beca, Jaclyn M, Arias, Jessica, Raphael, Michael J., Parmar, Ambica, Crespo, Andrea, Cheung, Matthew C, Eisen, Andrea, Eskander, Antoine, Singh, Simron, Trudeau, Maureen, Gavura, Scott, Dai, Wei Fang, Irish, Jonathan, Krzyzanowska, Monika, Lapointe-Shaw, Lauren, Naipaul, Rohini, Peacock, Stuart, Yeung, Lyndee, Forbes, Leta, Chan, Kelvin K. W.
Publicado 2022

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue...

por Parmar, Ambica, Dai, Wei Fang, Dionne, Francois, Geirnaert, Marc, Denburg, Avram, Ahuja, Tarry, Beca, Jaclyn, Bouchard, Sylvie, Chambers, Carole, Hunt, Melissa J., Husereau, Don, Lungu, Elena, McDonald, Valerie, Mercer, Rebecca E., Mitera, Gunita, Muñoz, Caroline, Naipaul, Rohini, Peacock, Stuart, Potashnik, Tanya, Tadrous, Mina, Takhar, Pam, Taylor, Marianne, Trudeau, Maureen, Wasney, Danica, Gavura, Scott, Chan, Kelvin K. W.
Publicado 2023